Company Filing History:
12 out of 2,009 
1 out of 40 
Years Active: 1998-2015
Title: Eli Gilboa: Innovator in Cancer and Pathogen Treatment
Introduction
Eli Gilboa is a prominent inventor based in Durham, NC (US), known for his significant contributions to the field of cancer and pathogen treatment. With a total of 12 patents, he has made remarkable strides in developing innovative methods that leverage antigen-presenting cells for therapeutic purposes.
Latest Patents
One of Eli Gilboa's latest patents focuses on methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA. This invention discloses cells and methods aimed at treating or preventing tumor formation or infections with pathogens in patients. The cells involved are antigen-presenting cells, such as dendritic cells or macrophages, which have been loaded with RNA derived from tumors or pathogens. By administering these RNA-loaded antigen-presenting cells to patients, it is possible to treat or prevent tumor formation or pathogen infections. Additionally, the RNA-loaded cells can serve as stimulator cells in the ex vivo expansion of cytotoxic T lymphocytes (CTL), which can then be utilized in various adoptive immunotherapy techniques.
Career Highlights
Eli Gilboa has had a distinguished career, working with notable institutions such as Duke University and Argos Therapeutics, Inc. His work has been pivotal in advancing the understanding and treatment of cancers and infectious diseases.
Collaborations
Throughout his career, Eli has collaborated with esteemed colleagues, including Smita K Nair and David J Boczkowski. These collaborations have further enriched his research and contributed to the development of innovative therapeutic strategies.
Conclusion
Eli Gilboa's innovative work in the field of cancer and pathogen treatment exemplifies the impact of research and invention on healthcare. His contributions continue to pave the way for new therapeutic approaches that hold promise for patients worldwide.